PYRIDOSTIGMINE BROMIDE | N009829 | BAUSCH HEALTH US LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Amendment to Suitability Petition from Rising Pharma Holdings, Inc. FDA-2025-P-4986 · 7 docket documents Rising Pharma Holdings, Inc. submitted an amendment to its suitability petition FDA-2025-P-4986 on October 28, 2025, providing proposed product labeling for Pyridostigmine Bromide Oral Solution, USP 120 mg/5 mL in response to the FDA's October 23, 2025 information request, as required under 21 CFR 3 | Suitability | 2025-10-29 | Open | Rising Pharma Holdings, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.